908 DEVICES INC. (MASS) Quick Ratio
- Quick ratio · latest quarter: Value 2.29×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 2.29× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. $113.24M ÷ $49.42M ≈ 2.29× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 113.24M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 49.42M USD | Liabilities, Current |
| Cash and equivalents | 63.02M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 38.51M USD | Marketable Securities, Current · Debt Securities, Available-for-sale, Current |
| Customer receivables | 11.71M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 14.37M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $113.24M | $49.42M | $63.02M | $38.51M | $11.71M | $14.37M | 2.29× |
| 2026-03-31 | $121.61M | $39.66M | $67.56M | $44.18M | $9.87M | $13.24M | 3.07× |
| 2025-12-31 | $124.30M | $34.06M | $70.52M | $42.45M | $11.33M | $12.99M | 3.65× |
| 2025-09-30 | $123.05M | $41.48M | $62.80M | $49.25M | $11.00M | $15.33M | 2.97× |
| 2025-06-30 | $124.79M | $29.71M | $61.75M | $56.83M | $6.21M | $15.46M | 4.20× |
| 2025-03-31 | $131.25M | $19.56M | $79.16M | $45.15M | $6.93M | $12.74M | 6.71× |
| 2024-12-31 | $82.23M | $25.15M | $44.03M | $25.57M | $12.63M | $16.17M | 3.27× |
| 2024-09-30 | $88.34M | $25.72M | $45.02M | $26.66M | $16.66M | $17.83M | 3.44× |
| 2024-06-30 | $88.37M | $21.72M | $46.81M | $30.57M | $10.99M | $18.59M | 4.07× |
| 2024-03-31 | $141.68M | $19.33M | $104.60M | $29.60M | $7.49M | $16.36M | 7.33× |
| 2023-12-31 | $154.67M | $22.55M | $121.04M | $24.64M | $8.99M | $14.94M | 6.86× |
| 2023-09-30 | $160.78M | $22.32M | $118.21M | $29.68M | $12.88M | $15.93M | 7.20× |
| 2023-06-30 | $163.00M | $20.19M | $133.00M | $19.69M | $10.31M | $14.13M | 8.07× |
| 2023-03-31 | (m) | $18.66M | $161.21M | (m) | $8.17M | $13.37M | (m) |
| 2022-12-31 | (m) | $19.23M | $188.42M | (m) | $10.03M | $12.51M | (m) |
| 2022-09-30 | (m) | $19.08M | $193.70M | (m) | $15.23M | $11.73M | (m) |
| 2022-06-30 | (m) | $15.43M | $212.99M | (m) | $11.10M | $11.18M | (m) |
| 2022-03-31 | (m) | $13.66M | $223.12M | (m) | $6.32M | $9.63M | (m) |
| 2021-12-31 | (m) | $14.84M | $224.07M | (m) | $16.38M | $7.92M | (m) |
| 2021-09-30 | (m) | $13.06M | $138.81M | (m) | $8.29M | $8.27M | (m) |
| 2021-06-30 | (m) | $11.18M | $141.31M | (m) | $5.32M | $7.95M | (m) |
| 2021-03-31 | (m) | $9.25M | $148.96M | (m) | $4.37M | $6.82M | (m) |
| 2020-12-31 | (m) | $10.83M | $159.23M | (m) | $6.83M | $4.57M | (m) |
| 2020-09-30 | (m) | (m) | $19.71M | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | $11.34M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | $14.66M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |